<DOC>
	<DOCNO>NCT02356835</DOCNO>
	<brief_summary>This 10-week , randomize , control study evaluate efficacy safety APT001 plasma nitric oxide treatment subject diabetic foot ulcer .</brief_summary>
	<brief_title>APT001 Plasma/NO Generator Treat Diabetic Foot Ulcer Adults</brief_title>
	<detailed_description>Approximately 80 subject randomize computer receive equally either sham therapy plasma / nitric oxide treatment topically . The nitric oxide / plasma treatment deliver 11.5 15 centimeter wind surface 10 second per cm2 wound size . Subjects evaluate efficacy safety regular basis clinical observation . The wound group treat sharp debridement determine site Investigator . A collagen dressing , non-adherent dressing , absorptive dressing apply wound either study therapy sham therapy . For initial safety evaluation patient DFU , first ten patient randomize limited wound size 7 cm2 less wound assess 2-4 day treatment session . Following completion final assessment 10 patient , data submit FDA review approval open enrolment remain patient .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>19 80 year age Type 1 2 diabetes hemoglobin A1c le 12 % ABI ≥ 0.7 , palpable pulse and/or biphasic waveform study Doppler Wound size ≥ 1cm2 ≤ 30cm2 ( first 10 patient enrol limited wound size 7 cm2 less ) Have significant concomitant illness would adversely affect participation study affect heal wound Have severe infection ulcer include presence abscess , cellulitis extend &gt; 2 cm beyond ulcer margin , osteomyelitis Have involvement deep tissue include bone tendon Be currently receive steroid medication , chemotherapy , medication might affect heal wound Have receive topical systemic antimicrobial therapy within 48 hour screen Have malignancy skin cancer currently treat Have substance abuse issue within 6 month prior screen Is woman pregnant breast feeding Has treat another investigational product within 30 day screen Has treat tissue engineer skin biological therapy within 30 day screen</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>